Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.44 Billion 2.11 Billion 2.86 Billion 3.57 Billion 732.83 Million 987.66 Million
Total Current Assets 1.24 Billion 1.72 Billion 2.38 Billion 3.1 Billion 348.24 Million 682.47 Million
Cash And Short Term Investments 1.16 Billion 1.58 Billion 2.2 Billion 2.92 Billion 253.52 Million 125.15 Million
Cash and Cash Equivalents 1.16 Billion 1.58 Billion 2.2 Billion 2.92 Billion 253.52 Million 125.15 Million
Short Term Investments - - - - - -
Net Receivables - - 1.00 - - 581 Thousand
Inventory 5.66 Million 47.4 Million 49.65 Million 31.46 Million 25.26 Million 25.24 Million
Other Current Assets 69.97 Million 84.04 Million 136.28 Million 140.19 Million 69.45 Million 531.49 Million
Total Non-Current Assets 205.75 Million 394.93 Million 476.26 Million 472.04 Million 384.59 Million 305.19 Million
Net PPE 60.13 Million 205.21 Million 223.36 Million 229.16 Million 224.69 Million 241.3 Million
Good Will And Intangible Assets 110.09 Million 163.2 Million 171.04 Million 156.93 Million 94.31 Million 16.03 Million
Good Will 17.81 Million 21.75 Million 21.75 Million 21.75 Million 21.75 Million -
Intangible Assets 92.28 Million 141.45 Million 149.29 Million 135.18 Million 72.56 Million 16.03 Million
Long-Term Investments -8.35 Million - - - - -
Tax Assets 8.35 Million 6.91 Million 5.73 Million 5.64 Million 680 Thousand -
Other Non Current Assets 35.51 Million 19.6 Million 76.12 Million 80.3 Million 64.9 Million 47.85 Million
Other Assets - - - - - -
Total Liabilities 256.17 Million 309.87 Million 369.73 Million 336.32 Million 507.37 Million 164.05 Million
Total Current Liabilities 229.52 Million 260.39 Million 313.18 Million 248.73 Million 360.12 Million 99.65 Million
Account Payables 141.66 Million 132.15 Million 129.66 Million 91.73 Million 103.36 Million 30.86 Million
Tax Payables 1.84 Million 2.23 Million 3.5 Million 2.35 Million 638 Thousand 331 Thousand
Short Term Debt 3.23 Million 6.76 Million 37.3 Million 15.04 Million 12.41 Million 8.95 Million
Deferred Revenue -3.06 Million - - - - -
Other Current Liabilities 87.69 Million 121.47 Million 146.22 Million 141.95 Million 244.34 Million 59.83 Million
Total Non Current Liabilities 26.65 Million 49.47 Million 56.54 Million 87.59 Million 147.25 Million 64.39 Million
Long-Term Debt 3.92 Million 21.82 Million 20.1 Million 16.01 Million 29.35 Million 35.79 Million
Deferred Revenue Non Current 10.57 Million 13.98 Million 18.14 Million 22.65 Million 23.64 Million 28.6 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 559 Thousand 1.23 Million 5 Million 34.79 Million 79.28 Million 28.6 Million
Other Liabilities - - - - - -
Total Equity 1.19 Billion 1.8 Billion 2.49 Billion 3.23 Billion 225.46 Million 823.6 Million
Stock Holders Equity 1.18 Billion 1.8 Billion 2.49 Billion 3.23 Billion 218.98 Million 823.6 Million
Common Stock 69 Thousand 69 Thousand 68 Thousand 67 Thousand 39 Thousand 15 Thousand
Retained Earnings -6.79 Billion -6.11 Billion -5.38 Billion -4.52 Billion -1.49 Billion -971.35 Million
Accumulated other comprehensive income -1.41 Billion -1.45 Billion -1.4 Billion -1.42 Billion -209.35 Million 331.31 Million
Common Stock Equity 1.18 Billion 1.8 Billion 2.49 Billion 3.23 Billion 218.98 Million 823.6 Million
Capital Lease Obligation 7.15 Million 28.58 Million 27.7 Million 31.05 Million 41.76 Million 44.75 Million
Total Investments -8.35 Million - - - - -
Total Debt 7.15 Million 28.58 Million 57.4 Million 31.05 Million 41.76 Million 44.75 Million
Net Debt -1.15 Billion -1.56 Billion -2.14 Billion -2.89 Billion -211.75 Million -80.4 Million

Balance Sheet Charts